Shun-Qing Liang

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	1462	1344
h-endeksi	19	18
i10-endeksi	25	24

420

210

105

315

2014201520162017201820192020202120222023202420258 4 16 25 17 38 113 168 257 349 410 47

Genel erişim

Tümünü görüntüle

25 makale

0 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Ren-Wang PengUniversity Hospital Bern, University of Berninsel.ch üzerinde doğrulanmış e-posta adresine sahip
Wen Xuethe RNA Therapeutics Institute at the University of Massachusetts Medical Schoolumassmed.edu üzerinde doğrulanmış e-posta adresine sahip
Thomas Michael MartiUniversity Hospital Berninsel.ch üzerinde doğrulanmış e-posta adresine sahip
Haitang YangShanghai Chest Hospital, Shanghai Jiao Tong University School Of Medicineshsmu.edu.cn üzerinde doğrulanmış e-posta adresine sahip
Erik SontheimerRNA Therapeutics Institute, UMass Medical Schoolumassmed.edu üzerinde doğrulanmış e-posta adresine sahip
Prof. Dr. Sabina BerezowskaPathologist, Institute of Pathology, University Hospital Lausanne (CHUV) and University of Lausannechuv.ch üzerinde doğrulanmış e-posta adresine sahip
Sean HallSenior Scientist, Divsion of Thoracic Surgery, University Hospital Berninsel.ch üzerinde doğrulanmış e-posta adresine sahip
Pengpeng LiuMolecular, Cell and Cancer Biology department, UMass Chan Medical Schoolsustech.edu.cn üzerinde doğrulanmış e-posta adresine sahip
GuangPing Gaoumassmed.edu üzerinde doğrulanmış e-posta adresine sahip
Rémy BruggmannUniversity of Bernbioinformatics.unibe.ch üzerinde doğrulanmış e-posta adresine sahip
Bin LiuUniversity of Massachusetts Medical Schoolumassmed.edu üzerinde doğrulanmış e-posta adresine sahip
Suet-Yan KwanUMass Medical Schoolumassmed.edu üzerinde doğrulanmış e-posta adresine sahip
Zexiang ChenPostdoctoral Researcher, UT Southwestern Medical Centerutsouthwestern.edu üzerinde doğrulanmış e-posta adresine sahip
Terence R FlotteProfessor, Dean, Provost, University of Massachusetts Medical Schoolumassmed.edu üzerinde doğrulanmış e-posta adresine sahip
Carsten RietherPrincipal Investigator at the Department for BioMedical Research, University of Bern, Switzerlanddbmr.unibe.ch üzerinde doğrulanmış e-posta adresine sahip
Xiaolong DongUniversity of Massachusetts Medical Schoolumassmed.edu üzerinde doğrulanmış e-posta adresine sahip
Tomás C RodríguezMD/PhD Candidate, University of Massachusetts Medical Schoolumassmed.edu üzerinde doğrulanmış e-posta adresine sahip
Daniel G. AndersonMassachusetts Institute of Technologymit.edu üzerinde doğrulanmış e-posta adresine sahip
haiwei mouWistar Institutewistar.org üzerinde doğrulanmış e-posta adresine sahip
Erik VassellaHead molecular pathology, University of Bernpathology.unibe.ch üzerinde doğrulanmış e-posta adresine sahip

Takip et

Shun-Qing Liang

Assistant Professor, University of Minnesota Twin Cities

umn.edu üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Cancer Research Gene Therapy CRISPR Editing Prime editing


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice P Liu, SQ Liang, C Zheng, E Mintzer, YG Zhao, K Ponnienselvan, A Mir, ... Nature communications 12 (1), 2121, 2021	241	2021
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing B Li, RS Manan, SQ Liang, A Gordon, A Jiang, A Varley, G Gao, R Langer, ... Nature biotechnology 41 (10), 1410-1415, 2023	141	2023
New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness H Yang, SQ Liang, RA Schmid, RW Peng Frontiers in oncology 9, 953, 2019	139	2019
A split prime editor with untethered reverse transcriptase and circular RNA template B Liu, X Dong, H Cheng, C Zheng, Z Chen, TC Rodríguez, SQ Liang, ... Nature Biotechnology 40 (9), 1388-1393, 2022	125	2022
Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins J Lee, H Mou, R Ibraheim, SQ Liang, P Liu, W Xue, EJ Sontheimer Rna 25 (11), 1421-1431, 2019	99	2019
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer SQ Liang, TM Marti, P Dorn, L Froment, SRR Hall, S Berezowska, ... Cell death & disease 6 (7), e1824-e1824, 2015	89	2015
A flexible split prime editor using truncated reverse transcriptase improves dual-AAV delivery in mouse liver C Zheng, SQ Liang, B Liu, P Liu, SY Kwan, SA Wolfe, W Xue Molecular Therapy 30 (3), 1343-1351, 2022	87	2022
HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer H Yang, SQ Liang, D Xu, Z Yang, TM Marti, Y Gao, GJ Kocher, H Zhao, ... Oncogenesis 8 (9), 45, 2019	53	2019
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer SQ Liang, ED Bührer, S Berezowska, TM Marti, D Xu, L Froment, H Yang, ... Oncogene 38 (5), 622-636, 2019	51	2019
Genome-wide detection of CRISPR editing in vivo using GUIDE-tag SQ Liang, P Liu, JL Smith, E Mintzer, S Maitland, X Dong, Q Yang, J Lee, ... Nature communications 13 (1), 437, 2022	42	2022
Endoplasmic reticulum stress signaling as a therapeutic target in malignant pleural mesothelioma D Xu, H Yang, Z Yang, S Berezowska, Y Gao, SQ Liang, TM Marti, ... Cancers 11 (10), 1502, 2019	36	2019
CRISPR screening identifies WEE1 as a combination target for standard chemotherapy in malignant pleural mesothelioma D Xu, SQ Liang, H Yang, R Bruggmann, S Berezowska, Z Yang, TM Marti, ... Molecular cancer therapeutics 19 (2), 661-672, 2020	35	2020
Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma D Xu, SQ Liang, H Yang, U Lüthi, C Riether, S Berezowska, TM Marti, ... British journal of cancer 119 (1), 65-75, 2018	35	2018
Genome-wide profiling of prime editor off-target sites in vitro and in vivo using PE-tag SQ Liang, P Liu, K Ponnienselvan, S Suresh, Z Chen, C Kramme, ... Nature Methods 20 (6), 898-907, 2023	34	2023
AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway SQ Liang, CJ Walkey, AE Martinez, Q Su, ME Dickinson, D Wang, ... Molecular Therapy 30 (1), 238-243, 2022	34	2022
Immune response of turbot (Scophthalmus maximus L.) to a broad spectrum vaccine candidate, recombinant glyceraldehyde-3-phosphate dehydrogenase of Edwardsiella tarda S Liang, H Wu, B Liu, J Xiao, Q Wang, Y Zhang Veterinary immunology and immunopathology 150 (3-4), 198-205, 2012	34	2012
Secreted glyceraldehyde‐3‐phosphate dehydrogenase as a broad spectrum vaccine candidate against microbial infection in aquaculture X Li, H Wu, M Zhang, S Liang, J Xiao, Q Wang, Q Liu, Y Zhang Letters in applied microbiology 54 (1), 1-9, 2012	32	2012
Analysis of unexpected small cell lung cancer following surgery as the primary treatment H Yang, J Xu, F Yao, S Liang, H Zhao Journal of cancer research and clinical oncology 144, 2441-2447, 2018	22	2018
YAP1 withdrawal in hepatoblastoma drives therapeutic differentiation of tumor cells to functional hepatocyte‐like cells JL Smith, TC Rodríguez, H Mou, SY Kwan, H Pratt, XO Zhang, Y Cao, ... Hepatology 73 (3), 1011-1027, 2021	20	2021
CRISPR-mediated kinome editing prioritizes a synergistic combination therapy for FGFR1-amplified lung cancer Z Yang, SQ Liang, H Yang, D Xu, R Bruggmann, Y Gao, H Deng, ... Cancer research 81 (11), 3121-3133, 2021	18	2021

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar